These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 488546)

  • 1. Patient-controlled portable insulin infusion pump in diabetics.
    Bojsen J; Deckert T; Kølendorf K; Lørup B
    Diabetes; 1979 Nov; 28(11):974-9. PubMed ID: 488546
    [No Abstract]   [Full Text] [Related]  

  • 2. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A portable, pre-programmable insulin infusion system in diabetes mellitus.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.
    Gertner JM; Tamborlane WV; Horst RL; Sherwin RS; Felig P; Genel M
    J Clin Endocrinol Metab; 1980 May; 50(5):862-6. PubMed ID: 6246134
    [No Abstract]   [Full Text] [Related]  

  • 6. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
    Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waveform requirements for metabolic normalization with continuous intravenous insulin delivery in man.
    Perlman K; Ehrlich RM; Filler RM; Albisser AM
    Diabetes; 1981 Sep; 30(9):710-7. PubMed ID: 7021271
    [No Abstract]   [Full Text] [Related]  

  • 10. Remission of insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, recent onset diabetics: role of beta cell recovery and lymphocyte subsets distribution.
    Guastamacchia E; Nardelli GM; Di Paolo S; Lattanzi V; Ciampolillo A; Lacasella R; Montedoro P; Giorgino R
    Diabete Metab; 1988; 14(2):138-9. PubMed ID: 3042488
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of postprandial exercise in type I diabetes: comparison between the continuous-infusion insulin pump and intensified conventional therapy].
    Goicolea I; Rueda M; Hernández I; Quiroga A; Vázquez JA
    Rev Clin Esp; 1986 Nov; 179(7):355-8. PubMed ID: 3541079
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
    Raskin P; Pietri A; Unger R
    Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portable insulin infusion systems in juvenile-onset diabetes.
    Tamborlane WV
    Hosp Pract; 1980 Oct; 15(10):91-9. PubMed ID: 6998857
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of brittle diabetics by a pre-planned insulin infusion programme.
    Deckert T; Lorup B
    Diabetologia; 1976 Dec; 12(6):573-9. PubMed ID: 1001846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.
    Køolendorf K; Bojsen J; Løorup B
    Diabetologia; 1980; 18(2):141-5. PubMed ID: 6988273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus.
    Christiansen JS; Frandsen M; Parving HH
    Diabetologia; 1981 Mar; 20(3):199-204. PubMed ID: 7014321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.